CJC-1295 With DAC
Made in the USACJC-1295 with DAC is a modified growth-hormone-releasing hormone analogue designed to bind circulating albumin. This structural feature extends its persistence compared with the natural hormone. Researchers study its activity at the GHRH receptor and the resulting growth-hormone and IGF-1 responses, providing insight into sustained signaling within the endocrine growth axis.
Primary research focus: Hormonal & Growth Axis. This description is not a medical indication.
Presentations & pricing
5mg · $455
Select a presentation above to update the vial, label and inquiry. The team confirms availability and next steps.
Research information only; this page does not provide dosing, prescribing or treatment instructions. Verify regulatory status and documentation for the applicable product and lot.